NCT07649226

Brief Summary

Crown lengthening surgery is one of the most commonly performed periodontal procedures. Multiple techniques have been used throughout the years to overcome the postoperative pain and adverse outcomes that may be associated with surgical crown lengthening. One of the most popular choices among clinicians is using different types of lasers in different techniques to overcome those adverse effects. Treatment effectiveness can be monitored non-invasively through salivary levels of Leukocyte Esterase enzyme and the stability clinical outcomes.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 30, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

June 4, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 16, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Completed
Last Updated

June 16, 2026

Status Verified

March 1, 2026

Enrollment Period

2 months

First QC Date

June 4, 2026

Last Update Submit

June 12, 2026

Conditions

Keywords

altered passive eruptionperiodontologyleukocyte esteraseesthetic crown lengthening

Outcome Measures

Primary Outcomes (3)

  • leukocyte esterase enzyme assessment using Periomonitor

    Periomonitor strips will be used to detect the amount of leukocyte esterase enzyme in saliva

    1 month

  • Clinical outcome stability

    Clinical outcome stability will be assessed by measuring the length of the crown and interdental papillae immediately postoperatively, 1 week postoperatively, 1 month postoperatively, 3 months postoperatively and 6 months postoperatively.

    6 months

  • PROM

    Binary questionnaire (Yes/No) questions will be asked.

    1 week

Secondary Outcomes (1)

  • Marginal bone loss evaluated using CBCT

    6 months

Study Arms (3)

conventional surgical crown lenhthening

ACTIVE COMPARATOR

gold standard of treatment

Procedure: surgical esthetic crown lengthening

Laser assissted flapless approach

ACTIVE COMPARATOR
Procedure: laser assissted crown lengthening

Tunneled flap approach

ACTIVE COMPARATOR
Procedure: Laser-assisted tunneled flap approach

Interventions

laser-assissted flapless crown lengthening and laser-assissted tunneled flap approach

Laser assissted flapless approach

surgical crown lengthening using scalpels and rotary instruments.

conventional surgical crown lenhthening

In this approach, the gingival margin will be tunneled to provide visibility for the operator during bone removal using laser.

Tunneled flap approach

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with an excessive gingival display of at least 3 mm
  • Age \>21 years
  • At least six anterior maxillary teeth requiring ECL
  • Healthy periodontal status, indicated by a full-mouth plaque index and bleeding on probing index scores of \<15%.
  • Patients with thick gingival phenotype

You may not qualify if:

  • Treatment sites with probing depths more than 3 mm
  • Patients with a history of smoking
  • Patients with a history of mucogingival surgery in the intended treatment area
  • Systemic conditions that could hinder tissue healing (e.g., uncontrolled diabetes and autoimmune diseases)
  • Patients undergoing active orthodontic treatment
  • Presence of any cause of excessive gingival display other than altered passive eruption

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alexandria University

Alexandria, Alexandria Governorate, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2026

First Posted

June 16, 2026

Study Start

March 30, 2026

Primary Completion

June 1, 2026

Study Completion

September 1, 2026

Last Updated

June 16, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations